Mercedes Villacampa-Martinez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort study.

Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort study.

Journal: International journal of colorectal disease

Published: May 25, 2023

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.

Journal: JAMA network open

Published: October 19, 2020

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.

Journal: BMC cancer

Published: November 08, 2019

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 16, 2017

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 23, 2017

Results of surgery for pelvic recurrence of rectal cancer. Experience in a referral center.

Results of surgery for pelvic recurrence of rectal cancer. Experience in a referral center.

Journal: Cirugia espanola

Published: July 20, 2016

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells.

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells.

Journal: Oncotarget

Published: May 11, 2016

First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours.

First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 19, 2015

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 29, 2014

Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.

Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.

Journal: BMC cancer

Published: April 07, 2014

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

Journal: BMC cancer

Published: April 07, 2014

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: September 15, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026